PMVP
PMV Pharmaceuticals, Inc.$1.44-0.01 (-0.35%)Prev Close$1.44·MCap$76.8M·P/E—·Vol160.6K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
2
$54.7K
◆
Net Activity
Net Seller
$54.7K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at PMV Pharmaceuticals, Inc. (PMVP) has been exclusively selling, with 0 insider purchases totaling $0.00 and 2 insider sales totaling $54.7K. The most recent insider transaction was by Carulli Michael (Chief Financial Officer), who sold $30.1K worth of shares on Jul 1, 2025. PMV Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $76.8M.
PMVP Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | Carulli Michael | Chief Financial Officer | Sell | 28,249 | $1.06 | $30.1K | 0 |
| Jul 1, 2025 | Ticktin Robert | General Counsel & COO | Sell | 23,151 | $1.06 | $24.7K | 0 |
| Sep 12, 2024 | Carulli Michael | Chief Financial Officer | Sell | 2,891 | $1.50 | $4.3K | 88,395 |
| Sep 12, 2024 | Jalota Deepika | Chief Development Officer | Sell | 7,218 | $1.50 | $10.9K | 118,283 |
| Nov 24, 2023 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 87,786 | $2.23 | $195.8K | 0Exit |
| Sep 18, 2023 | Alland Leila | Chief Medical Officer | Sell | 6,291 | $6.62 | $41.6K | 45,909 |
| Sep 18, 2023 | Jalota Deepika | Chief Development Officer | Sell | 4,104 | $6.62 | $27.2K | 29,946 |
| May 31, 2022 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 26,253 | $15.93 | $418.2K | 87,786 |
| Mar 31, 2022 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 474,500 | $21.63 | $10.26M0.9% OS | 109,500-81% |
| Oct 8, 2021 | Schroeder Thilo | Director | Sell | 800 | $30.15 | $24.1K | 1,101,283 |
| Oct 4, 2021 | Schroeder Thilo | Director | Sell | 14,619 | $30.09 | $439.8K | 1,113,724 |
| Sep 29, 2021 | Schroeder Thilo | Director | Sell | 7,461 | $30.06 | $224.3K | 1,122,410 |
| Sep 24, 2021 | Schroeder Thilo | Director | Sell | 100 | $30.00 | $3.0K | 1,124,163 |
| Sep 23, 2021 | LEVINE ARNOLD J | Director | Sell | 3,500 | $30.00 | $105.0K | 409,842 |
| Sep 21, 2021 | Schroeder Thilo | Director | Sell | 711 | $30.03 | $21.4K | 1,124,263 |
| Sep 13, 2021 | Schroeder Thilo | Director | Sell | 70,828 | $30.41 | $2.15M | 1,181,473 |
| Sep 10, 2021 | Alland Leila | Chief Medical Officer | Sell | 100 | $30.25 | $3.0K | 0Exit |
| Sep 8, 2021 | Alland Leila | Chief Medical Officer | Sell | 3,900 | $30.25 | $118.0K | 0Exit |
| Sep 2, 2021 | Schroeder Thilo | Director | Sell | 46,906 | $30.25 | $1.42M | 1,223,188 |
| Aug 30, 2021 | Schroeder Thilo | Director | Sell | 58,829 | $30.45 | $1.79M | 1,286,474 |
| Aug 25, 2021 | Schroeder Thilo | Director | Sell | 51,854 | $30.87 | $1.60M | 1,614,669 |
| Aug 24, 2021 | LEVINE ARNOLD J | Director | Sell | 3,500 | $29.50 | $103.3K | 413,342 |
| Aug 20, 2021 | Schroeder Thilo | Director | Sell | 30,664 | $33.05 | $1.01M | 1,657,040 |
| Aug 18, 2021 | Jalota Deepika | SVP, Regulatory Affairs and QA | Sell | 2,896 | $33.78 | $97.8K | 0Exit |
| Aug 17, 2021 | Schroeder Thilo | Director | Sell | 80,491 | $33.89 | $2.73M | 1,723,176 |
| Aug 12, 2021 | Schroeder Thilo | Director | Sell | 68,480 | $34.36 | $2.35M | 1,799,537 |
| Aug 10, 2021 | Alland Leila | Chief Medical Officer | Sell | 4,471 | $34.04 | $152.2K | 1,802-71% |
| Aug 9, 2021 | Schroeder Thilo | Director | Sell | 77,693 | $36.23 | $2.81M | 1,868,264 |
| Aug 4, 2021 | Kung Winston | COO, CFO | Sell | 4,500 | $33.82 | $152.2K | 1,600-74% |
| Aug 4, 2021 | Schroeder Thilo | Director | Sell | 96,136 | $35.05 | $3.37M | 1,978,240 |
| Jul 30, 2021 | Schroeder Thilo | Director | Sell | 11,024 | $35.75 | $394.1K | 1,993,571 |
| Jul 27, 2021 | Schroeder Thilo | Director | Sell | 17,362 | $35.91 | $623.5K | 2,007,669 |
| Jul 23, 2021 | Schroeder Thilo | Director | Sell | 18,872 | $35.82 | $676.0K | 2,019,857 |
| Jul 22, 2021 | LEVINE ARNOLD J | Director | Sell | 3,500 | $35.12 | $122.9K | 416,842 |
| Jul 22, 2021 | Mack David Henry | President and CEO | Sell | 27,796 | $35.75 | $993.7K | 12,470-69% |
| Jul 8, 2021 | Alland Leila | Chief Medical Officer | Sell | 4,000 | $32.30 | $129.2K | 2,049-66% |
| Jul 8, 2021 | Kung Winston | COO, CFO | Sell | 4,500 | $33.75 | $151.9K | 1,600-74% |
| Jun 29, 2021 | Mack David Henry | President and CEO | Sell | 204 | $35.53 | $7.2K | 12,470 |
| Jun 22, 2021 | LEVINE ARNOLD J | Director | Sell | 3,500 | $33.25 | $116.4K | 420,453 |
| Jun 15, 2021 | Euclidean Capital LLC | 10% Owner | Sell | 66,396 | $34.01 | $2.26M | 2,521,280 |
| Jun 11, 2021 | Euclidean Capital LLC | 10% Owner | Sell | 60,271 | $33.31 | $2.01M | 2,545,002 |
| Jun 9, 2021 | Euclidean Capital LLC | 10% Owner | Sell | 62,445 | $33.50 | $2.09M | 2,584,736 |
| Jun 8, 2021 | Alland Leila | Chief Medical Officer | Sell | 4,000 | $33.60 | $134.4K | 1,367-75% |
| Jun 7, 2021 | Kung Winston | COO, CFO | Sell | 4,500 | $33.75 | $151.9K | 1,600-74% |
| Jun 2, 2021 | Heyman Richard A. | Director | Sell | 3,898 | $32.55 | $126.9K | 558-87% |
| Jun 2, 2021 | Schroeder Thilo | Director | Sell | 5,100 | $35.80 | $182.6K | 2,038,529 |
| May 27, 2021 | Schroeder Thilo | Director | Sell | 16,005 | $35.79 | $572.9K | 2,051,116 |
| May 24, 2021 | Mack David Henry | President and CEO | Sell | 14,000 | $35.65 | $499.1K | 2,470-85% |
| May 24, 2021 | Schroeder Thilo | Director | Sell | 44,780 | $35.92 | $1.61M | 2,101,503 |
| May 21, 2021 | LEVINE ARNOLD J | Director | Sell | 3,500 | $34.51 | $120.8K | 426,803 |
Showing 1–50 of 60
1 / 2
PMVP Insider Buying Activity
The following table shows recent insider purchases of PMV Pharmaceuticals, Inc. (PMVP) stock reported via SEC Form 4 filings.
No insider buying activity found for PMVP in the last 12 months.
PMVP Insider Selling Activity
The following table shows recent insider sales of PMV Pharmaceuticals, Inc. (PMVP) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | Carulli Michael | Chief Financial Officer | Sell | 28,249 | $1.06 | $30.1K | 0 |
| Jul 1, 2025 | Ticktin Robert | General Counsel & COO | Sell | 23,151 | $1.06 | $24.7K | 0 |
| Sep 12, 2024 | Carulli Michael | Chief Financial Officer | Sell | 2,891 | $1.50 | $4.3K | 88,395 |
| Sep 12, 2024 | Jalota Deepika | Chief Development Officer | Sell | 7,218 | $1.50 | $10.9K | 118,283 |
| Nov 24, 2023 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 87,786 | $2.23 | $195.8K | 0Exit |
| Sep 18, 2023 | Alland Leila | Chief Medical Officer | Sell | 6,291 | $6.62 | $41.6K | 45,909 |
| Sep 18, 2023 | Jalota Deepika | Chief Development Officer | Sell | 4,104 | $6.62 | $27.2K | 29,946 |
| May 31, 2022 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 26,253 | $15.93 | $418.2K | 87,786 |
| Mar 31, 2022 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 474,500 | $21.63 | $10.26M0.9% OS | 109,500-81% |
| Oct 8, 2021 | Schroeder Thilo | Director | Sell | 800 | $30.15 | $24.1K | 1,101,283 |
| Oct 4, 2021 | Schroeder Thilo | Director | Sell | 14,619 | $30.09 | $439.8K | 1,113,724 |
| Sep 29, 2021 | Schroeder Thilo | Director | Sell | 7,461 | $30.06 | $224.3K | 1,122,410 |
| Sep 24, 2021 | Schroeder Thilo | Director | Sell | 100 | $30.00 | $3.0K | 1,124,163 |
| Sep 23, 2021 | LEVINE ARNOLD J | Director | Sell | 3,500 | $30.00 | $105.0K | 409,842 |
| Sep 21, 2021 | Schroeder Thilo | Director | Sell | 711 | $30.03 | $21.4K | 1,124,263 |
| Sep 13, 2021 | Schroeder Thilo | Director | Sell | 70,828 | $30.41 | $2.15M | 1,181,473 |
| Sep 10, 2021 | Alland Leila | Chief Medical Officer | Sell | 100 | $30.25 | $3.0K | 0Exit |
| Sep 8, 2021 | Alland Leila | Chief Medical Officer | Sell | 3,900 | $30.25 | $118.0K | 0Exit |
| Sep 2, 2021 | Schroeder Thilo | Director | Sell | 46,906 | $30.25 | $1.42M | 1,223,188 |
| Aug 30, 2021 | Schroeder Thilo | Director | Sell | 58,829 | $30.45 | $1.79M | 1,286,474 |
| Aug 25, 2021 | Schroeder Thilo | Director | Sell | 51,854 | $30.87 | $1.60M | 1,614,669 |
| Aug 24, 2021 | LEVINE ARNOLD J | Director | Sell | 3,500 | $29.50 | $103.3K | 413,342 |
| Aug 20, 2021 | Schroeder Thilo | Director | Sell | 30,664 | $33.05 | $1.01M | 1,657,040 |
| Aug 18, 2021 | Jalota Deepika | SVP, Regulatory Affairs and QA | Sell | 2,896 | $33.78 | $97.8K | 0Exit |
| Aug 17, 2021 | Schroeder Thilo | Director | Sell | 80,491 | $33.89 | $2.73M | 1,723,176 |
| Aug 12, 2021 | Schroeder Thilo | Director | Sell | 68,480 | $34.36 | $2.35M | 1,799,537 |
| Aug 10, 2021 | Alland Leila | Chief Medical Officer | Sell | 4,471 | $34.04 | $152.2K | 1,802-71% |
| Aug 9, 2021 | Schroeder Thilo | Director | Sell | 77,693 | $36.23 | $2.81M | 1,868,264 |
| Aug 4, 2021 | Kung Winston | COO, CFO | Sell | 4,500 | $33.82 | $152.2K | 1,600-74% |
| Aug 4, 2021 | Schroeder Thilo | Director | Sell | 96,136 | $35.05 | $3.37M | 1,978,240 |
| Jul 30, 2021 | Schroeder Thilo | Director | Sell | 11,024 | $35.75 | $394.1K | 1,993,571 |
| Jul 27, 2021 | Schroeder Thilo | Director | Sell | 17,362 | $35.91 | $623.5K | 2,007,669 |
| Jul 23, 2021 | Schroeder Thilo | Director | Sell | 18,872 | $35.82 | $676.0K | 2,019,857 |
| Jul 22, 2021 | LEVINE ARNOLD J | Director | Sell | 3,500 | $35.12 | $122.9K | 416,842 |
| Jul 22, 2021 | Mack David Henry | President and CEO | Sell | 27,796 | $35.75 | $993.7K | 12,470-69% |
| Jul 8, 2021 | Alland Leila | Chief Medical Officer | Sell | 4,000 | $32.30 | $129.2K | 2,049-66% |
| Jul 8, 2021 | Kung Winston | COO, CFO | Sell | 4,500 | $33.75 | $151.9K | 1,600-74% |
| Jun 29, 2021 | Mack David Henry | President and CEO | Sell | 204 | $35.53 | $7.2K | 12,470 |
| Jun 22, 2021 | LEVINE ARNOLD J | Director | Sell | 3,500 | $33.25 | $116.4K | 420,453 |
| Jun 15, 2021 | Euclidean Capital LLC | 10% Owner | Sell | 66,396 | $34.01 | $2.26M | 2,521,280 |
| Jun 11, 2021 | Euclidean Capital LLC | 10% Owner | Sell | 60,271 | $33.31 | $2.01M | 2,545,002 |
| Jun 9, 2021 | Euclidean Capital LLC | 10% Owner | Sell | 62,445 | $33.50 | $2.09M | 2,584,736 |
| Jun 8, 2021 | Alland Leila | Chief Medical Officer | Sell | 4,000 | $33.60 | $134.4K | 1,367-75% |
| Jun 7, 2021 | Kung Winston | COO, CFO | Sell | 4,500 | $33.75 | $151.9K | 1,600-74% |
| Jun 2, 2021 | Heyman Richard A. | Director | Sell | 3,898 | $32.55 | $126.9K | 558-87% |
| Jun 2, 2021 | Schroeder Thilo | Director | Sell | 5,100 | $35.80 | $182.6K | 2,038,529 |
| May 27, 2021 | Schroeder Thilo | Director | Sell | 16,005 | $35.79 | $572.9K | 2,051,116 |
| May 24, 2021 | Mack David Henry | President and CEO | Sell | 14,000 | $35.65 | $499.1K | 2,470-85% |
| May 24, 2021 | Schroeder Thilo | Director | Sell | 44,780 | $35.92 | $1.61M | 2,101,503 |
| May 21, 2021 | LEVINE ARNOLD J | Director | Sell | 3,500 | $34.51 | $120.8K | 426,803 |
PMVP Insiders
Similar Stocks to PMVP
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B